CARAC

LOE Approaching

fluorouracil cream, 0.5%

NDATOPICALCREAM
Approved
Oct 2000
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1

Mechanism of Action

Nucleic Acid Synthesis Inhibitors

Pharmacologic Class:

Nucleoside Metabolic Inhibitor

Clinical Trials (1)

NCT06712381Phase 1/2Completed

Carac & PDT Combination in the Treatment Of Actinic Keratoses

Started Aug 2008
60 enrolled
Actinic Keratoses
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers